CA2056431A1 - Photosensibilisation de derives de la porphyrine obtenus par additions diels-alder - Google Patents
Photosensibilisation de derives de la porphyrine obtenus par additions diels-alderInfo
- Publication number
- CA2056431A1 CA2056431A1 CA002056431A CA2056431A CA2056431A1 CA 2056431 A1 CA2056431 A1 CA 2056431A1 CA 002056431 A CA002056431 A CA 002056431A CA 2056431 A CA2056431 A CA 2056431A CA 2056431 A1 CA2056431 A1 CA 2056431A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- aryl
- alkyl
- compound
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36318589A | 1989-06-07 | 1989-06-07 | |
| US363,185 | 1989-06-07 | ||
| PCT/CA1990/000191 WO1990015059A1 (fr) | 1989-06-07 | 1990-06-07 | Derives de porphyrine de diels-alder utilises comme photosensibilisateurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2056431A1 true CA2056431A1 (fr) | 1990-12-08 |
Family
ID=23429184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002056431A Abandoned CA2056431A1 (fr) | 1989-06-07 | 1990-06-07 | Photosensibilisation de derives de la porphyrine obtenus par additions diels-alder |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0476011A1 (fr) |
| JP (1) | JPH05501857A (fr) |
| AU (1) | AU641658B2 (fr) |
| CA (1) | CA2056431A1 (fr) |
| WO (1) | WO1990015059A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9014307D0 (en) * | 1990-06-27 | 1990-08-15 | Scient Generics Ltd | Method of treatment and compositions therefor |
| EP0649667B1 (fr) * | 1993-10-20 | 2001-02-28 | Antonella Aprile Carpenter | Appareil thérapeutique de stimulation biologique à niveau d'énergie quantique |
| DE19514087A1 (de) * | 1995-04-13 | 1996-10-17 | Deutsches Krebsforsch | Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein |
| US6444194B1 (en) * | 1997-02-14 | 2002-09-03 | Miravant Pharmaceuticals, Inc. | Indium photosensitizers for PDT |
| US6756396B1 (en) | 1997-05-07 | 2004-06-29 | Qlt Inc. | Ethylene glycol esters as photoactive agents |
| CZ294715B6 (cs) * | 1997-05-07 | 2005-02-16 | Qlt Inc. | Ethylenglykol estery monohydrobenzoporfyrinových derivátů jako fotoaktivní činidla |
| US10919904B2 (en) | 2016-08-17 | 2021-02-16 | North Carolina State University | Northern-southern route to synthesis of bacteriochlorins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986001720A1 (fr) * | 1984-09-13 | 1986-03-27 | Cytogen Corporation | Conjugues d'agents therapeutiques-anticorps |
| US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
| US4883790A (en) * | 1987-01-20 | 1989-11-28 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| EP0434727A4 (en) * | 1988-09-08 | 1994-08-17 | Ultra Diagnostic Corp | Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
-
1990
- 1990-06-07 CA CA002056431A patent/CA2056431A1/fr not_active Abandoned
- 1990-06-07 AU AU58164/90A patent/AU641658B2/en not_active Ceased
- 1990-06-07 WO PCT/CA1990/000191 patent/WO1990015059A1/fr not_active Ceased
- 1990-06-07 JP JP2508586A patent/JPH05501857A/ja active Pending
- 1990-06-07 EP EP90909118A patent/EP0476011A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU5816490A (en) | 1991-01-07 |
| AU641658B2 (en) | 1993-09-30 |
| JPH05501857A (ja) | 1993-04-08 |
| EP0476011A1 (fr) | 1992-03-25 |
| WO1990015059A1 (fr) | 1990-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0641796B1 (fr) | Agents cytotoxiques de longueur d'onde spécifique | |
| US5095030A (en) | Wavelength-specific cytotoxic agents | |
| AU618725B2 (en) | Wavelength-specific cytotoxic agents | |
| US5308608A (en) | Photosensitizing Diels-Alder porphyrin derivatives | |
| US5149708A (en) | Photosensitizing Diels-Alder porphyrin derivatives | |
| AU683856B2 (en) | Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof | |
| US5053423A (en) | Compositions for photodynamic therapy | |
| US5238940A (en) | Compositions for photodynamic therapy | |
| US5190966A (en) | Purified hematoporphyrin dimers and trimers useful in photodynamic therapy | |
| US4968715A (en) | Use of purified hematoporphyrin trimers in photodynamic therapy | |
| US5171749A (en) | Wavelength-specific cytotoxic agents | |
| US5283255A (en) | Wavelength-specific cytotoxic agents | |
| AU697139B2 (en) | Porphocyanine and CNC-expanded porphyrins | |
| CA2056431A1 (fr) | Photosensibilisation de derives de la porphyrine obtenus par additions diels-alder | |
| US5064952A (en) | Derivatives of porphyrin useful in photodynamic therapy | |
| NO179410B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive monobenzofyriner og anvendelse av disse | |
| JPH0780887B2 (ja) | 波長特異的細胞毒性試薬 | |
| MXPA96004956A (en) | Porfocianin and porfirinas extended with |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |